In The News — 12 February 2014

Professor Robert E. Mcclean and his team of researchers from Oxford University, using gene therapy, have improved conditions of patients living with choroideremia, a severe genetic defect that causes blindness.

Six months after the injections, the team conducting the trial found the retinas in all of the patients had improved sensitivity to light and that two patients had substantially improved vision. These two patients had the most advanced form of choroideremia, and after they received the treatment they were able to correctly read an extra two and four lines on an eye chart, respectively. No adverse effects from the injection were recorded in the trial.

Read the full article here!

Share

About Author

Elan Meltzer

(0) Readers Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>